Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01251770Phase 3Completed
Phase 3, randomised trial of sodium chloride in hyponatremia (2 arms), sponsored by Hospital General de Niños Pedro de Elizalde. Primary endpoint: Change in Sodium Levels at 12 hours. Started Dec 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01251770.